Literature DB >> 7727625

Choline ingestion increases the resonance of choline-containing compounds in human brain: an in vivo proton magnetic resonance study.

A L Stoll1, P F Renshaw, E De Micheli, R Wurtman, S S Pillay, B M Cohen.   

Abstract

Choline is a crucial intermediate in several clinically relevant neurochemical processes. In this study, choline-containing compounds in human brain (principally phosphocholine, glycero-phosphocholine, and choline) were measured by 1H-magnetic resonance spectroscopy, before and after the ingestion of 50 mg/kg choline in four normal control subjects. Substantial and remarkably similar increases in the brain choline resonance occurred in each subject, with a nearly two-fold rise in the choline resonance observed 3 hr following choline ingestion (p = 0.008 versus baseline). One subject also received a dose of 200 mg/kg choline, and exhibited a proportionally larger increase in the brain choline resonance. The results are consistent with animal data reporting a rise in choline-containing compounds following choline administration. This is the first study to our knowledge where an oral nutrient has been shown to produce a detectable change in human brain composition in vivo. Studying choline transport and biotransformation in human brain may have relevance to several neuropsychiatric disorders, including affective disorders and dementia.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7727625     DOI: 10.1016/0006-3223(94)00120-R

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  10 in total

Review 1.  MR spectroscopy and spectroscopic imaging of the brain.

Authors:  He Zhu; Peter B Barker
Journal:  Methods Mol Biol       Date:  2011

Review 2.  Imaging Biomarkers of the Neuroimmune System among Substance Use Disorders: A Systematic Review.

Authors:  Eric A Woodcock; Ansel T Hillmer; Graeme F Mason; Kelly P Cosgrove
Journal:  Mol Neuropsychiatry       Date:  2019-05-09

3.  Differential effect of CDP-choline on brain cytosolic choline levels in younger and older subjects as measured by proton magnetic resonance spectroscopy.

Authors:  S M Babb; K E Appelmans; P F Renshaw; R J Wurtman; B M Cohen
Journal:  Psychopharmacology (Berl)       Date:  1996-09       Impact factor: 4.530

Review 4.  A guide to the metabolic pathways and function of metabolites observed in human brain 1H magnetic resonance spectra.

Authors:  Caroline D Rae
Journal:  Neurochem Res       Date:  2013-11-21       Impact factor: 3.996

Review 5.  Contributions of studies on alcohol use disorders to understanding cerebellar function.

Authors:  Natalie M Zahr; Anne-Lise Pitel; Sandra Chanraud; Edith V Sullivan
Journal:  Neuropsychol Rev       Date:  2010-09-01       Impact factor: 7.444

6.  In vivo evidence for alcohol-induced neurochemical changes in rat brain without protracted withdrawal, pronounced thiamine deficiency, or severe liver damage.

Authors:  Natalie M Zahr; Dirk Mayer; Shara Vinco; Juan Orduna; Richard Luong; Edith V Sullivan; Adolf Pfefferbaum
Journal:  Neuropsychopharmacology       Date:  2008-08-13       Impact factor: 7.853

7.  Oral administration of choline does not affect metabolic characteristics of gliomas and normal-appearing white matter, as detected with single-voxel (1)H-MRS at 1.5 T.

Authors:  Mikhail F Chernov; Yoshihiro Muragaki; Takashi Maruyama; Yuko Ono; Masao Usukura; Shigetoshi Yoshida; Ryoichi Nakamura; Hiroshi Iseki; Osami Kubo; Tomokatsu Hori; Kintomo Takakura
Journal:  Neuroradiology       Date:  2008-10-24       Impact factor: 2.804

8.  Oral choline supplementation for postoperative pain.

Authors:  N Sidhu; S Davies; A Nadarajah; J Rivera; R Whittington; R J Mercier; L Virag; S Wang; P Flood
Journal:  Br J Anaesth       Date:  2013-04-07       Impact factor: 9.166

9.  Brain choline concentrations may not be altered in euthymic bipolar disorder patients chronically treated with either lithium or sodium valproate.

Authors:  Ren H Wu; Tina O'Donnell; Michele Ulrich; Sheila J Asghar; Christopher C Hanstock; Peter H Silverstone
Journal:  Ann Gen Hosp Psychiatry       Date:  2004-07-30

Review 10.  Advances in high-field magnetic resonance spectroscopy in Alzheimer's disease.

Authors:  Ningnannan Zhang; Xiaowei Song; Robert Bartha; Steven Beyea; Ryan D'Arcy; Yunting Zhang; Kenneth Rockwood
Journal:  Curr Alzheimer Res       Date:  2014-05       Impact factor: 3.498

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.